The Norwegian Radium Hospital, The Research Building
Jarle Bruun defended his thesis "Biomarkers with functional and clinical impact on colorectal cancer" the 24th of April, with professor David Kerr, University of Oxford, and professor Leonor David, University of Porto, as opponents.
Bruun’s work was presented in Dagens Medisin the 24th of April and on forskning.no the 17th of May.
In a recent Article in Nature Cell Biology, PhD student Sigrid B. Thoresen and her co-workers in Harald Stenmark’s group at Institute for Cancer Research and Centre for Cancer Biomedicine have uncovered a cellular mechanism that prevents completion of cell division if “lagging” chromosomes are detected in the bridge between the two forming daughter cells. This prevents occurrence of cells with abnormal numbers of chromosomes, aneuploidy. Since aneuploidy is strongly associated with cancer progression, these results open new possibilities for future cancer diagnosis and therapy.
The Fridtjof Nansen prize for excellent research in science and medicine 2014 is awarded to CCB's Kirsten Sandvig for her groundbreaking work within biochemistry and cell biology.
In April six research prizes were awarded to scientists from Oslo University Hospital. CCB researcher Marianne B. Eide was among the prize winners.
Wednesday the 30th of April, Group leader Guro E. Lind participated in the radio program Ekko to talk about epigenetics and colorectal cancer.
Lind was invited speaker at the Oslo Epigenetics Symposium that took place from the 9th-11th of April. The Ekko program based its news story on this important international conference.